JENNIFFER NAVEDO: Open Payments
NPI 1720463771 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,319 in 182 payments from 18 companies in 2025. Trend: 2023 $3,808 · 2024 $3,570 · 2025 $5,319
Food & beverage: $5,250Education: $69
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 29 | $950 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $646 |
| GlaxoSmithKline, LLC. | 25 | $619 |
| Grifols USA, LLC | 17 | $592 |
| JAZZ PHARMACEUTICALS INC. | 9 | $406 |
| GENZYME CORPORATION | 11 | $388 |
| Regeneron Healthcare Solutions, Inc. | 24 | $345 |
| Verona Pharma, Inc. | 20 | $286 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $233 |
| Lilly USA, LLC | 8 | $203 |
Products named: DUPIXENT, Prolastin-C Liquid, FASENRA, NUCALA, XYWAV, Ohtuvayre, AIRSUPRA, ZEPBOUND.
Industry payments across FL — which companies pay providers there.
